While our study established associations between LMP2, PSME1, PSME2 expression (via transcriptomic/database analysis and IHC in a clinical cohort) and NACI response/survival outcomes, the IHC correlations do not establish a causal role for these immunoproteasome subunits in anti-tumor immunity. The gene discussed is PSME2; the disease is neoplasm.